Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
Study NCT ID:
NCT03401112
Status:
COMPLETED
Last Update Posted:
2025-05-15
First Post:
2018-01-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)
Sponsor:
Cardurion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-26
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-28
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-02
First Submit QC Date:
None
Study First Post Date:
2018-01-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-08-27
Results First Submit QC Date:
None
Results First Post Date:
2022-04-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-13
Last Update Post Date:
2025-05-15
Last Update Post Date Type:
ACTUAL